http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9100973

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, U.S. Gov't, P.H.S.
endingPage 77
issn 0920-1211
issueIdentifier 2
pageRange 69-77
publicationName Epilepsy Research
startingPage 69
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e57a2df28cd3d691c9ebea9a73b49d7b
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_3a8e870027486d237d0d2364a9bbcda6
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b2f5e5ce7a03c8e1389bbc187f861057
bibliographicCitation Stringer JL. Ethosuximide specifically antagonizes the effect of pentylenetetrazol in the rat entorhinal cortex. Epilepsy Res. 1996 Oct;25(2):69–77. doi: 10.1016/0920-1211(96)00068-x. PMID: 8884166.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_044447323395cd40007944c46d9026d0
date 199610
identifier https://doi.org/10.1016/0920-1211%2896%2900068-x
https://pubmed.ncbi.nlm.nih.gov/8884166
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3587
https://portal.issn.org/resource/ISSN/0920-1211
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Ethosuximide specifically antagonizes the effect of pentylenetetrazol in the rat entorhinal cortex
discusses http://id.nlm.nih.gov/mesh/M0016203
http://id.nlm.nih.gov/mesh/M0007887
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D005013Q000494
http://id.nlm.nih.gov/mesh/D010433Q000494
http://id.nlm.nih.gov/mesh/D018728Q000187
http://id.nlm.nih.gov/mesh/D005071Q000187
hasSubjectTerm http://id.nlm.nih.gov/mesh/D051381
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D004305
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D017207
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5917
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5641
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7617
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9191

Total number of triples: 37.